![]() |
Influenza |
Free Subscription
7 Am J Med |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Influenza is free of charge.
Immune Response and Cognitive Impairment in Post-COVID Syndrome: A Systematic
Review.
Am J Med. 2025;138:698-711.
PubMed
Abstract available
Insights into Long COVID: Unraveling Risk Factors, Clinical Features,
Radiological Findings, Functional Sequelae and Correlations: A Retrospective
Cohort Study.
Am J Med. 2024 Sep 17:S0002-9343(24)00569-2. doi: 10.1016/j.amjmed.2024.
PubMed
Abstract available
Adult Outpatients with Long COVID Infected with SARS-CoV-2 Omicron Variant. Part
1: Oral Microbiota Alterations.
Am J Med. 2025;138:732-741.
PubMed
Abstract available
Synergistic Effect of SARS-CoV-2 Infection and COVID-19 Vaccination on the Risk
of Venous Thromboembolism.
Am J Med. 2025;138:673-680.
PubMed
Abstract available
Non-Invasive Brain Stimulation for Post-COVID-19 Conditions: A Systematic Review.
Am J Med. 2025;138:681-697.
PubMed
Abstract available
Long COVID Characteristics and Experience: A Descriptive Study From the Yale
LISTEN Research Cohort.
Am J Med. 2025;138:712-720.
PubMed
Abstract available
Post-Traumatic Stress Disorder and Complex Post-Traumatic Stress Disorder in
People with Long COVID, ME/CFS, and Controls.
Am J Med. 2025;138:742-749.
PubMed
Abstract available
Humoral immune response characteristics of vulnerable populations against
SARS-CoV-2 strains EG.5 and JN.1 after infection with strains BA.5 and XBB.
Arch Virol. 2025;170:82.
PubMed
Abstract available
Targeting the liquid-liquid phase separation of nucleocapsid broadly inhibits the
replication of SARS-CoV-2 strains.
Biochem Biophys Res Commun. 2025;756:151594.
PubMed
Abstract available
Structure and dynamics of Alpha B.1.1.7 SARS-CoV-2 S-protein in complex with Fab
of neutralizing antibody REGN10987.
Biochem Biophys Res Commun. 2025;755:151558.
PubMed
Abstract available
The severity of pediatric COVID-19 during hospitalization is not associated with
mortality within six months of discharge.
BMC Pediatr. 2025;25:199.
PubMed
Abstract available
Comparative analysis of croup severity and treatment in pediatric patient: a
study of COVID-19 positive vs. negative cases during peak Omicron.
BMC Pediatr. 2025;25:194.
PubMed
Abstract available
Global surveillance and countermeasures for ACE2-using MERS-related coronaviruses
with spillover risk.
Cell. 2025;188:1465-1468.
PubMed
Abstract available
Bat-infecting merbecovirus HKU5-CoV lineage 2 can use human ACE2 as a cell entry
receptor.
Cell. 2025;188:1729-1742.
PubMed
Abstract available
Are children and adolescents living with HIV in Europe and South Africa at higher
risk of SARS-CoV-2 and poor COVID-19 outcomes?
Epidemiol Infect. 2025;153:e44.
PubMed
Abstract available
Type I interferon autoantibody footprints reveal neutralizing mechanisms and
allow inhibitory decoy design.
J Exp Med. 2025;222:e20242039.
PubMed
Abstract available
Cathelicidin-related antimicrobial peptide (CRAMP) is toxic during neonatal
murine influenza virus infection.
J Immunol. 2025 Mar 18:vkae053. doi: 10.1093.
PubMed
Abstract available
Oral ADC189 for Adults and Adolescents with Uncomplicated Influenza.
J Infect. 2025 Mar 13:106472. doi: 10.1016/j.jinf.2025.106472.
PubMed
Abstract available
Assessing the impact of influenza epidemics in Hong Kong.
J Infect Dis. 2025 Mar 19:jiaf140. doi: 10.1093.
PubMed
Abstract available
IL-8 as a Causal Link Between Aging and Impaired Influenza Antibody Responses in
Older Adults.
J Infect Dis. 2025 Mar 17:jiaf148. doi: 10.1093.
PubMed
Abstract available
Impact of pandemic-induced service disruptions and behavioral changes on HCV and
HIV transmission amongst people who inject drugs: a modeling study.
J Infect Dis. 2024 Dec 6:jiae599. doi: 10.1093.
PubMed
Abstract available
Effective Real-time Transmission Estimations Incorporating Population Viral Load
Distributions Amid SARS-CoV-2 Variants and Preexisting Immunity.
J Infect Dis. 2025;231:684-691.
PubMed
Abstract available
A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus
Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants.
J Infect Dis. 2025;231:e478-e487.
PubMed
Abstract available
Development of High-Titer Antidrug Antibodies in a Phase 1b/2a Infant Clesrovimab
Trial Are Associated With RSV Exposure Beyond Day 150.
J Infect Dis. 2025;231:e488-e496.
PubMed
Abstract available
Ascertainment of Community Exposure Sites to Ross River Virus During the 2020
Outbreak in Brisbane, Australia.
J Infect Dis. 2025;231:e501-e510.
PubMed
Abstract available
Association of mRNA COVID-19 vaccination and reductions in Post-COVID Conditions
following SARS-CoV-2 infection in a US prospective cohort of essential workers.
J Infect Dis. 2024 Nov 13:jiae556. doi: 10.1093.
PubMed
Abstract available
Lower Levels of Household Transmission of SARS-CoV-2 Omicron Variant of Concern
vs Wild Type: An Interplay Between Transmissibility and Immune Status.
J Infect Dis. 2025;231:653-664.
PubMed
Abstract available
Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for
Biomarker-Guided Management of Coronavirus Disease 2019.
J Infect Dis. 2025;231:677-683.
PubMed
Abstract available
Respiratory Viral Infections From 2015 to 2022 in the HIVE Cohort of American
Households: Incidence, Illness Characteristics, and Seasonality.
J Infect Dis. 2025;231:795-804.
PubMed
Abstract available
Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior
virus growth at low temperatures.
J Virol. 2025 Feb 12:e0221724. doi: 10.1128/jvi.02217.
PubMed
Abstract available
Enhancing the solubility of SARS-CoV-2 inhibitors to increase future prospects
for clinical development.
J Virol. 2025 Feb 4:e0215924. doi: 10.1128/jvi.02159.
PubMed
Abstract available
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is
driven by target cell preservation coupled with incomplete viral clearance.
J Virol. 2025 Feb 4:e0162324. doi: 10.1128/jvi.01623.
PubMed
Abstract available
mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-gamma and IL-2 T-cell responses
are predictive of serological neutralization and are transiently enhanced by
pre-existing cross-reactive immunity.
J Virol. 2025 Jan 31:e0168524. doi: 10.1128/jvi.01685.
PubMed
Abstract available
Single-cell transcriptomics reveals a compartmentalized antiviral interferon
response in the nasal epithelium of mice.
J Virol. 2025 Feb 4:e0141324. doi: 10.1128/jvi.01413.
PubMed
Abstract available
PLSCR1 suppresses SARS-CoV-2 infection by downregulating cell surface ACE2.
J Virol. 2025 Feb 13:e0208524. doi: 10.1128/jvi.02085.
PubMed
Abstract available
Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as
a single dose primer and booster against SARS-CoV-2 variants.
J Virol. 2025 Mar 21:e0198924. doi: 10.1128/jvi.01989.
PubMed
Abstract available
A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1)
elicits protective and long-lasting immunity in nonhuman primates.
J Virol. 2025 Mar 21:e0199024. doi: 10.1128/jvi.01990.
PubMed
Abstract available
How immunity shapes the long-term dynamics of influenza H3N2.
PLoS Comput Biol. 2025;21:e1012893.
PubMed
Abstract available
Effectiveness of the Pfizer-BioNTech (BNT162b2) vaccine against the omicron
variant of SARS-CoV-2 among adults aged 50 and above: A case-control study in
Lebanon, June 2022.
PLoS One. 2025;20:e0318344.
PubMed
Abstract available
COVID-19 outbreak management in Western Sydney residential aged care homes: A
mixed-methods Donabedian evaluation.
PLoS One. 2025;20:e0318490.
PubMed
Abstract available
Factors influencing uptake of COVID-19 diagnostics in Sub-Saharan Africa: a rapid
scoping review.
PLoS One. 2025;20:e0305512.
PubMed
Abstract available
Three hospitalized non-critical COVID-19 subphenotypes and change in intubation
or death over time: A latent class analysis with external and longitudinal
validation.
PLoS One. 2025;20:e0316434.
PubMed
Abstract available
Diabetes with COVID-19 was a significant risk factor for mortality, mechanical
ventilation, and renal replacement therapies: A multicenter retrospective study
in Japan.
PLoS One. 2025;20:e0319801.
PubMed
Abstract available
Two-years mothering into the pandemic: Impact of the three COVID-19 waves in the
Argentinian postpartum women's mental health.
PLoS One. 2025;20:e0294220.
PubMed
Abstract available
Enhanced prediction of thrombotic events in hospitalized COVID-19 patients with
soluble thrombomodulin.
PLoS One. 2025;20:e0319666.
PubMed
Abstract available
Leveraging a digital network of pharmacy professionals to test a
technology-assisted model to improve pharmacy access to quality-assured COVID-19
rapid antigen tests approved for self-use in Vietnam.
PLoS One. 2025;20:e0318331.
PubMed
Abstract available
Neurologic manifestations of COVID-19 and viral test in cerebrospinal fluid.
PLoS One. 2025;20:e0312621.
PubMed
Abstract available
Coronavirus disease 2019 (COVID-19) vaccine acceptability in Ghana: An
urban-based population study.
PLoS One. 2025;20:e0319798.
PubMed
Abstract available
Access to lactation consult services during the COVID-19 pandemic and the impact
on breastfeeding outcome variables.
PLoS One. 2025;20:e0318749.
PubMed
Abstract available
The effect of exposure to the COVID-19 pandemic on nutritional status and
cognitive, motor, and behavioural development among children aged 20 months in
rural Bangladesh: A repeated cross-section study between 2020 and 2022.
PLoS One. 2025;20:e0309836.
PubMed
Abstract available
Technostress and its associated factors: Burnout and fatigue among Malaysian
healthcare workers (HCWs) in state hospitals.
PLoS One. 2025;20:e0319506.
PubMed
Abstract available
Governance and responses of health and surveillance systems to COVID-19 in BRICS
countries: A scoping review protocol.
PLoS One. 2025;20:e0319572.
PubMed
Abstract available
Long-term effects of the COVID-19 lockdown on the structural and functional
outcomes of neovascular AMD patients in Suzhou, China.
PLoS One. 2025;20:e0319677.
PubMed
Abstract available
Performance evaluation of reduced complexity deep neural networks.
PLoS One. 2025;20:e0319859.
PubMed
Abstract available
Noteworthy trends in maladaptive coping strategies and hindrances to help-seeking
behaviour among adolescents living in Malaysia's People's Housing Project (PPR)
during the COVID-19 pandemic: A qualitative study.
PLoS One. 2025;20:e0318381.
PubMed
Abstract available
Is there anything good about conspiracy beliefs? Belief in COVID-19 conspiracy
theories is associated with benefits to well-being.
PLoS One. 2025;20:e0319896.
PubMed
Abstract available
Role of leaders' positive mindset in mitigating the effects of crises on
organizations: The case of Canadian organizations.
PLoS One. 2025;20:e0319931.
PubMed
Abstract available
Deficiency in platelet 12-lipoxygenase exacerbates inflammation and disease
severity during SARS-CoV-2 infection.
Proc Natl Acad Sci U S A. 2025;122:e2420441122.
PubMed
Abstract available
Epidemic evolutionarily stable strategies within an age-structured host
population.
Proc Natl Acad Sci U S A. 2025;122:e2418170122.
PubMed
Abstract available
Ectopic germinal centers in the nasal turbinates contribute to B cell immunity to
intranasal viral infection and vaccination.
Proc Natl Acad Sci U S A. 2025;122:e2421724122.
PubMed
Abstract available
Factors associated with influenza and COVID-19 vaccination among health workers
in Lao PDR, 2023.
Vaccine. 2025;54:127006.
PubMed
Abstract available
A phase I study of the safety, reactogenicity and immunogenicity of two
quadrivalent seasonal influenza vaccines (Fluzone(R) or Flublok(R)) with or without
one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18-45 years of
age.
Vaccine. 2025;54:126991.
PubMed
Abstract available
Influenza vaccine effectiveness in Iceland 2014-2022: A test-negative design.
Vaccine. 2025;55:126981.
PubMed
Abstract available
Ghosts of the virus : unmasking the persistent threat of SARS-CoV-2 in Long
COVID.
Virologie (Montrouge). 2025;29:57-68.
PubMed
Abstract available
[Ghosts of the virus : unmasking the persistent threat of SARS-CoV-2 in Long
COVID].
Virologie (Montrouge). 2025;29:41-53.
PubMed
Abstract available
Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in
individuals from Cameroon.
Virology. 2025;605:110467.
PubMed
Abstract available
Thank you for your interest in scientific medicine.